Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MARIETTA, Ga., July 31, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended June 30, 2013.
Hey, check out all the research scientist jobs. Post your resume today!
